Impact of Errors and Variability on Clinical Laboratory Test Interpretation
暂无分享,去创建一个
[1] J O Westgard,et al. European specifications for imprecision and inaccuracy compared with operating specifications that assure the quality required by US CLIA proficiency-testing criteria. , 1994, Clinical chemistry.
[2] P. Li,et al. Mechanism of interference by hemoglobin in the determination of total bilirubin. I. Method of Malloy-Evelyn. , 1980, Clinical chemistry.
[3] B. Nordestgaard,et al. Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study. , 2011, Clinical chemistry.
[4] M. Zweig,et al. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.
[5] D. Mutch. Ovarian cancer: to screen or not to screen. , 2009, Obstetrics and gynecology.
[6] G J Kost,et al. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. , 2009, Archives of pathology & laboratory medicine.
[7] Yasmin S. Hamirani,et al. Safety of statins: effects on muscle and the liver. , 2005, Cleveland Clinic journal of medicine.
[8] D. Rudman,et al. Transport of drugs, hormones and fatty acids in lipemic serum. , 1972, The Journal of pharmacology and experimental therapeutics.
[9] Stuart R Lipsitz,et al. Reduction in specimen labeling errors after implementation of a positive patient identification system in phlebotomy. , 2010, American journal of clinical pathology.
[10] C. Fraser. Improved monitoring of differences in serial laboratory results. , 2011, Clinical chemistry.
[11] J. Cleeman,et al. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. , 1993, JAMA.
[12] J. Ladenson,et al. Patients as their own controls: use of the computer to identify "laboratory error". , 1975, Clinical chemistry.
[13] G. Umpierrez,et al. Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects , 2003, International Journal of Obesity.
[14] F. Fonseca-Wollheim,et al. Preanalytical Increase of Ammonia in Blood Specimens from Healthy Subjects , 1990 .
[15] C. Schmid,et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. , 2011, Kidney international.
[16] Samia Mora,et al. Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events , 2008, Circulation.
[17] J. Cleeman,et al. The prevalence of high blood cholesterol levels among adults in the United States. , 1989, JAMA.
[18] D S Young,et al. Effects of Drugs on Clinical Laboratory Tests , 1997, Clinical chemistry.
[19] Brennan,et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. , 1987, Clinical chemistry.
[20] L J Kricka,et al. Human anti-animal antibody interferences in immunological assays. , 1999, Clinical chemistry.
[21] B. Nordestgaard,et al. Fasting and Nonfasting Lipid Levels: Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction , 2008, Circulation.
[22] R. F. Roberts,et al. Comparison of serum and heparinized plasma samples for measurement of chemistry analytes. , 2004, Clinical chemistry.
[23] V. Narra,et al. Clinical and economic impact of falsely decreased calcium values caused by gadoversetamide interference. , 2008, AJR. American journal of roentgenology.
[24] D. Bruns,et al. Stabilization of glucose in blood specimens: mechanism of delay in fluoride inhibition of glycolysis. , 2008, Clinical chemistry.
[25] T. Daly,et al. Mechanisms of dopamine and dobutamine interference in biochemical tests that use peroxide and peroxidase to generate chromophore. , 1998, Clinical chemistry.
[26] H. P. Kang,et al. Model for predicting the impact of gadolinium on plasma calcium measured by the o-cresolphthalein method. , 2004, Clinical chemistry.
[27] P. Calmarza,et al. Lipemia interferences in routine clinical biochemical tests. , 2011, Biochemia medica.
[28] A. Jaffe,et al. Catecholamine interference in enzymatic creatinine assays. , 2009, Clinical Chemistry.
[29] G. Eknoyan,et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] A. Dofferhoff,et al. Pseudohyperkalemia and platelet counts. , 1991, The New England journal of medicine.
[31] Greg Ward,et al. Interferences in immunoassay. , 2004, The Clinical biochemist. Reviews.
[32] K. Kent,et al. Gadodiamide administration causes spurious hypocalcemia. , 2003, Radiology.
[33] M H Kroll,et al. Mechanism of interference with the Jaffé reaction for creatinine. , 1987, Clinical chemistry.
[34] M. Schambelan,et al. Pseudohyperkalemia caused by fist clenching during phlebotomy. , 1990, The New England journal of medicine.
[35] Callum G Fraser,et al. Reference change values , 2012, Clinical chemistry and laboratory medicine.
[36] M H Kroll,et al. Interference with clinical laboratory analyses. , 1994, Clinical chemistry.
[37] H. Black,et al. Racial differences in serum creatine kinase levels. , 1986, The American journal of medicine.
[38] G. Horowitz. Establishment and Use of Reference Values , 2012 .
[39] R. Pierre,et al. Pseudothrombocytopenia: a laboratory artifact with potentially serious consequences. , 1984, Mayo Clinic proceedings.
[40] S. Fortmann,et al. Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994). , 2000, The American journal of cardiology.
[41] D. Arber,et al. Quality management in the transfusion service: case studies in process improvement , 2011, Transfusion.
[42] P. Ridker,et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. , 2007, JAMA.
[43] A. Wu,et al. Bilirubin interference with determination of uric acid, cholesterol, and triglycerides in commercial peroxidase-coupled assays, and the effect of ferrocyanide. , 1986, Clinical chemistry.
[44] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[45] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[46] L. Kricka,et al. Interference by human anti-mouse antibody in two-site immunoassays. , 1990, Clinical chemistry.
[47] B. Astor,et al. Age and association of kidney measures with mortality and end-stage renal disease. , 2012, JAMA.
[48] C Ricós,et al. Current databases on biological variation: pros, cons and progress. , 1999, Scandinavian journal of clinical and laboratory investigation.
[49] J O Westgard,et al. Criteria for judging precision and accuracy in method development and evaluation. , 1974, Clinical chemistry.
[50] J O Westgard,et al. Allowable imprecision for laboratory tests based on clinical and analytical test outcome criteria. , 1994, Clinical chemistry.